CIP
ZYNE

Chartwell Investment Partners’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Chartwell Investment Partners’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-90,378
Closed -$1.53M – 445
2017
Q2 		$1.53M Buy
90,378
+14,978
+20% +$254K 0.06% 322
2017
Q1 		$1.52M Buy
+75,400
New +$1.52M 0.06% 317